Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Antonio Passaro
Sep 23, 2024, 20:18 |
Blog
Antonio Passaro: Honored to have presented the SOHO-02 clinical trial
Antonio Passaro shared a post on LinkedIn: "I am truly honored to have presented the…
Sep 7, 2024, 16:05 |
Blog
Antonio Passaro: Discussing the latest evidences on NSCLC harbouring EGFR mutations at ESMO24
Antonio Passaro shared a post on LinkedIn: "Join us at ESMO24 on Sunday, Sep 15, for…
Sep 2, 2024, 09:38 |
Insight
Antonio Passaro: EMA approves amivantamab in combination with chemo for treatment of advanced EGFR-mutated NSCLC after Osimertinib
Antonio Passaro, shared a post on X: "EMA approves amivantamab in combination with chemo for…
Aug 29, 2024, 16:15 |
Drugs
Antonio Passaro: European Commission approves amivantamab
Antonio Passaro shared on LinkedIn: "I'm proud to announce that, yesterday August 27, the European…
Jul 1, 2024, 15:01 |
Blog
Antonio Passaro: A significant milestone for the advancement and understanding of EGFR-mutated NSCLC
Antonio Passaro, shared a post on LinkedIn: "I am honored to have contributed, as investigator…
May 28, 2024, 08:21 |
Blog
Antonio Passaro's top 10 selection with explanation, among the lung cancer abstracts from ASCO24
Antonio Passaro, shared a post on X: ''ASCO24 is ready to start soon! Here, my top…
May 16, 2024, 05:38 |
Blog
Antonio Passaro: Fantastic discussion on the dynamic landscape of EGFR mutant lung cancer
Antonio Passaro, Lung cancer Oncologist and Researcher at IEO, recently shared on X: “Fantastic discussion…
Apr 23, 2024, 20:12 |
Blog
Antonio Passaro: An honor to have been a part of this significant manuscript, just out in Annals of Oncology driving forward the clinical development of ADCs
Antonio Passaro, Medical Director with Highly Specialized Position at IEO European Institute of Oncology, shared on…
Apr 23, 2024, 11:38 |
Insight
Antonio Passaro: ETOP IBCSG Partners Foundation's position statement on antibody-drug conjugates (ADC) in lung and breast cancer
Antonio Passaro, Lung cancer Oncologist and Researcher at IEO, recently shared on X: "Just out…
Apr 21, 2024, 18:13 |
Blog
Antonio Passaro: An intense yet incredibly rewarding day in Oporto
Antonio Passaro, Medical Director with Highly Specialized Position at IEO European Institute of Oncology, shared a…
1
2
3
All:
24
Posts:
1 - 10
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube